Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9494 | 1150 | 32.0 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
62 | 3 | CARDIAC & CARDIOVASCULAR SYSTEM//HEART FAILURE//PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 86105 |
942 | 2 | HEART FAILURE//ACUTE HEART FAILURE//EUROPEAN JOURNAL OF HEART FAILURE | 10944 |
9494 | 1 | FLOSEQUINAN//BTS 53 554//FIRST DOSE HYPOTENSION | 1150 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FLOSEQUINAN | authKW | 438906 | 2% | 72% | 23 |
2 | BTS 53 554 | authKW | 79653 | 0% | 100% | 3 |
3 | FIRST DOSE HYPOTENSION | authKW | 35400 | 0% | 67% | 2 |
4 | 3 METHYLSULPHONYLAMINO 1 METHYL 41H | authKW | 26551 | 0% | 100% | 1 |
5 | ACE INHIBITION HAEMODYNAMICS EXERCISE LONG TERM | authKW | 26551 | 0% | 100% | 1 |
6 | ACE INHIBITORS DURATION OF ACTION EFFICACY SAFETY | authKW | 26551 | 0% | 100% | 1 |
7 | ADRENOCEPTOR UP REGULATION | authKW | 26551 | 0% | 100% | 1 |
8 | ASSOCIATED CARDIOVASCULAR RISK | authKW | 26551 | 0% | 100% | 1 |
9 | BLOCKER ALPHA RECEPTOR | authKW | 26551 | 0% | 100% | 1 |
10 | BLOOD PRESSURE MONITORING 24 H | authKW | 26551 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 18048 | 49% | 0% | 564 |
2 | Medicine, General & Internal | 3322 | 26% | 0% | 294 |
3 | Pharmacology & Pharmacy | 1117 | 20% | 0% | 231 |
4 | Peripheral Vascular Diseases | 983 | 9% | 0% | 106 |
5 | Medicine, Research & Experimental | 38 | 3% | 0% | 39 |
6 | Geriatrics & Gerontology | 29 | 1% | 0% | 13 |
7 | Toxicology | 18 | 2% | 0% | 23 |
8 | Urology & Nephrology | 14 | 2% | 0% | 21 |
9 | Primary Health Care | 7 | 0% | 0% | 4 |
10 | Critical Care Medicine | 5 | 1% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CENT HOSP ANESTHESIOL SURG INTENS CARE | 26551 | 0% | 100% | 1 |
2 | CENT HOSP CARDIO P UNIT | 26551 | 0% | 100% | 1 |
3 | CENT HOSP PHARMACOL | 26551 | 0% | 100% | 1 |
4 | FEDERATIF RECH COEUR MUSCLES VAISSEAUX | 26551 | 0% | 100% | 1 |
5 | MED CARDIOL621 MEANS HALL1655 UPHAM DR | 26551 | 0% | 100% | 1 |
6 | RISK TOR REDUCT | 26551 | 0% | 100% | 1 |
7 | SERV CARDIOL 5400 GOUIN BLVD | 26551 | 0% | 100% | 1 |
8 | ST PANCRAS HOSP MED GERIATR MED | 26551 | 0% | 100% | 1 |
9 | THER EUT ELDERLY GRP | 26551 | 0% | 100% | 1 |
10 | CENT HOSP ANESTHESIOL | 13274 | 0% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH HEART JOURNAL | 12543 | 3% | 1% | 39 |
2 | GERIATRIC CARDIOVASCULAR MEDICINE | 10384 | 0% | 13% | 3 |
3 | AMERICAN HEART JOURNAL | 8774 | 6% | 0% | 69 |
4 | AMERICAN JOURNAL OF CARDIOLOGY | 7485 | 8% | 0% | 87 |
5 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 6469 | 5% | 0% | 52 |
6 | EUROPEAN HEART JOURNAL | 5041 | 4% | 0% | 44 |
7 | ACTA MEDICA SCANDINAVICA | 4586 | 2% | 1% | 19 |
8 | CARDIOLOGY | 3563 | 2% | 1% | 21 |
9 | MODERN CONCEPTS OF CARDIOVASCULAR DISEASE | 2963 | 0% | 3% | 4 |
10 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2902 | 3% | 0% | 30 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OSTER, JR , MATERSON, BJ , (1992) RENAL AND ELECTROLYTE COMPLICATIONS OF CONGESTIVE-HEART-FAILURE AND EFFECTS OF THERAPY WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS.ARCHIVES OF INTERNAL MEDICINE. VOL. 152. ISSUE 4. P. 704-710 | 51 | 74% | 40 |
2 | OSTER, JR , PRESTON, RA , MATERSON, BJ , (1994) FLUID AND ELECTROLYTE DISORDERS IN CONGESTIVE-HEART-FAILURE.SEMINARS IN NEPHROLOGY. VOL. 14. ISSUE 5. P. 485-505 | 54 | 48% | 5 |
3 | MULROW, CD , MULROW, JP , LINN, WD , AGUILAR, C , RAMIREZ, G , (1988) RELATIVE EFFICACY OF VASODILATOR THERAPY IN CHRONIC CONGESTIVE HEART-FAILURE - IMPLICATIONS OF RANDOMIZED TRIALS.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 259. ISSUE 23. P. 3422-3426 | 31 | 82% | 41 |
4 | PACKER, M , (1988) VASODILATOR AND INOTROPIC DRUGS FOR THE TREATMENT OF CHRONIC HEART-FAILURE - DISTINGUISHING HYPE FROM HOPE.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. VOL. 12. ISSUE 5. P. 1299-1317 | 61 | 37% | 117 |
5 | BOREK, M , CHARLAP, S , FRISHMAN, WH , (1989) ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN HEART-FAILURE.MEDICAL CLINICS OF NORTH AMERICA. VOL. 73. ISSUE 2. P. 315-338 | 43 | 53% | 6 |
6 | PACKER, M , KUKIN, ML , NEUBERG, GW , PINSKY, DJ , PENN, J , ABITTAN, MH , (1989) THE CURRENT STATUS OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS IN THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART-FAILURE.JOURNAL OF HYPERTENSION. VOL. 7. ISSUE . P. S33-S36 | 25 | 89% | 4 |
7 | RYDEN, L , (1988) WHEN AND HOW TO USE ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN CONGESTIVE HEART-FAILURE.AMERICAN JOURNAL OF CARDIOLOGY. VOL. 62. ISSUE 2. P. A75-A80 | 23 | 100% | 7 |
8 | GUYATT, GH , (1986) THE TREATMENT OF HEART-FAILURE - A METHODOLOGICAL REVIEW OF THE LITERATURE.DRUGS. VOL. 32. ISSUE 6. P. 538-568 | 56 | 43% | 32 |
9 | DEEDWANIA, PC , (1990) ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN CONGESTIVE HEART-FAILURE.ARCHIVES OF INTERNAL MEDICINE. VOL. 150. ISSUE 9. P. 1798-1805 | 28 | 60% | 28 |
10 | MITROVIC, V , MUDRA, H , BONZEL, T , SCHMIDT, W , SCHLEPPER, M , (1996) HEMODYNAMIC AND HORMONAL EFFECTS OF A PARENTERAL THERAPY WITH THE ACE INHIBITOR QUINAPRILAT IN PATIENTS WITH ADVANCED HEART FAILURE.ZEITSCHRIFT FUR KARDIOLOGIE. VOL. 85. ISSUE 11. P. 828-838 | 17 | 77% | 2 |
Classes with closest relation at Level 1 |